Medicine & Life Sciences
2,4-thiazolidinedione
13%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
30%
Biguanides
8%
Blood Glucose
10%
BTS 67582
9%
Diabetes Complications
7%
Dipeptidyl Peptidase 4
11%
Dipeptidyl-Peptidase IV Inhibitors
13%
Fatty Acids
15%
Gastric Inhibitory Polypeptide
11%
Glucagon
11%
Glucagon-Like Peptide 1
22%
glucagon-like peptide 1 (7-36)amide
7%
Glucagon-Like Peptide-1 Receptor
11%
Glucose
75%
Hormones
7%
Hyperglycemia
21%
Hypoglycemia
15%
Hypoglycemic Agents
48%
Incretins
10%
Insulin
68%
Insulin Resistance
28%
Insulin Secretion
18%
Insulin-Secreting Cells
7%
Islets of Langerhans Transplantation
9%
Leptin
7%
Liver
8%
lixisenatide
8%
LY3298176
7%
Meals
7%
Metformin
76%
Obese Mice
7%
Obesity
18%
Palmitates
15%
Peptides
15%
Peroxisome Proliferator-Activated Receptors
10%
Pharmaceutical Preparations
10%
Pioglitazone
8%
Placebos
10%
PPAR gamma
8%
Rosiglitazone
13%
Safety
10%
sibutramine
10%
Sodium-Glucose Transport Proteins
9%
Sodium-Glucose Transporter 2 Inhibitors
9%
Symporters
7%
Therapeutics
16%
Thiazolidinediones
11%
Type 2 Diabetes Mellitus
100%
Weight Loss
11%
Chemistry
Antidiabetic Agent
20%
Ceramide
5%
Fatty Acid
7%
Glucagon-Like Peptide 1
9%
Glucose
19%
Glycemic
5%
Hormone
5%
Insulin Derivative
38%
Insulinotropic
19%
Leptin
7%
Metabolic
8%
Metformin
20%
Peptide
5%
Plasma
5%
Polypeptide
9%
Resistance
5%
Saturated Fatty Acid
7%